Latest filing published 13 Nov 2017 for easyJet plc, €25.
Insider track record
Carolyn McCall: trading record in brief
All filings by Carolyn McCall on record concern easyJet plc. In total, 16 filings cover trades dated from 19 November 2014 to 10 November 2017.
No open-market purchase appears, only 1 sale worth €2.5M. Besides market trades, the filings include 15 share grants.
On 13 November 2017 came the latest disclosure, a share grant for €25 in easyJet plc. Filings reach the RNS (LSE) feed a median of 2 days after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Companies and markets linked to Carolyn McCall
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22 shares@ £6.196.1% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20171113164645_13429870_20200330131534430_10566-3
- 24 shares@ £6.196.6% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20171011124742_13393473_20200330131537680_7493-3
- 26 shares@ £5.9057.0% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20170913114838_13361569_20200330131540286_8966-4
- 20 shares@ £7.185.3% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20170711151449_13291391_20200330131517132_7849-4
- 24 shares@ £6.6656.7% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20170614130843_13260455_20200330131522366_11448-3
- 22 shares@ £6.5656.4% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20170512131714_13224160_20200330131530959_10411-3
- 14 shares@ £10.604.0% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20170411175536_13191466_20200330131459238_8089-3
- 15 shares@ £9.824.2% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20170313173532_13156828_20200330131526301_10254-3
- 31 shares@ £4.93428.9% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20170214170206_13127710_20200330131513856_9699-3
- 30 shares@ £4.9058.8% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20161213171054_013066034_20200330143549132_9799-3
- 30 shares@ £5.248.4% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20161114132612_013034368_20200330143612377_11160-3
- 34 shares@ £4.419.2% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20161012103552_012998275_20200330143616204_8595-3
- 26 shares@ £5.75337.2% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20160913163019_012964647_20200330143619581_9735-5
- 28 shares@ £5.39687.6% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20160812135811_012929915_20200330143544413_10988-5
- 28 shares@ £5.40887.6% of flowXLONISIN GB00B7KR2P84FCA-NSM:LSE20160713151628_012891457_20200330143558233_10177-5
- 130,000 shares@ £15.427FCA-NSM:LSE20141120133853_012157465_20200330172031273_11632-0
16 of 16 declarations